Panipenem/betamipron
 | This article needs additional citations for verification. (December 2009) |
Panipenem/betamipron is a carbapenem antibiotic[1] marketed by Daiichi Sankyo Co. of Japan. It was launched in 1993, under the brand name Carbenin.
It is a combination in which panipenem is the carbapenem antibiotic and betamipron is a renal inhibitor[2] and inhibits renal uptake of panipenem and also from nephrotoxicity (much like the imipenem/cilastatin combination)
References
- ^ "Comparative antibacterial activity of carbapenems against P. aeruginosa (1)". 2010.
{{cite journal}}: Cite journal requires|journal=(help) - ^ Finch, Roger G. (2003). Antibiotic and chemotherapy: anti-infective agents and their use in therapy. Elsevier Health Sciences. pp. 269–. ISBN 978-0-443-07129-4. Retrieved 8 August 2011.
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |